Literature DB >> 26165840

Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.

R Mir1, S J Pradhan1, P Patil2, R Mulherkar3, S Galande1,4.   

Abstract

The chromatin organizer SATB1 has been implicated in the development and progression of multiple cancers including breast and colorectal cancers. However, the regulation and role of SATB1 in colorectal cancers is poorly understood. Here, we demonstrate that expression of SATB1 is induced upon hyperactivation of Wnt/β-catenin signaling and repressed upon depletion of TCF7L2 (TCF4) and β-catenin. Using several colorectal cancer cell line models and the APC min mutant zebrafish in vivo model, we established that SATB1 is a novel target of Wnt/β-catenin signaling. We show that direct binding of TCF7L2/β-catenin complex on Satb1 promoter is required for the regulation of SATB1. Moreover, SATB1 is sufficient to regulate the expression of β-catenin, members of TCF family, multiple downstream effectors and mediators of Wnt pathway. SATB1 potentiates the cellular changes and expression of key cancer-associated genes in non-aggressive colorectal cells, promotes their aggressive phenotype and tumorigenesis in vivo. Conversely, depletion of SATB1 from aggressive cells reprograms the expression of cancer-associated genes, reverses their cancer phenotype and reduces the potential of these cells to develop tumors in vivo. We also show that SATB1 and β-catenin bind to the promoters of TCF7L2 and the downstream targets of Wnt signaling and regulate their expression. Our findings suggest that SATB1 shares a feedback regulatory network with TCF7L2/β-catenin signaling and is required for Wnt signaling-dependent regulation of β-catenin. Collectively, these results provide unequivocal evidence to establish that SATB1 reprograms the expression of tumor growth- and metastasis-associated genes to promote tumorigenesis and functionally overlaps with Wnt signaling critical for colorectal cancer tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26165840     DOI: 10.1038/onc.2015.232

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.

Authors:  Curtis A Thorne; Alison J Hanson; Judsen Schneider; Emilios Tahinci; Darren Orton; Christopher S Cselenyi; Kristin K Jernigan; Kelly C Meyers; Brian I Hang; Alex G Waterson; Kwangho Kim; Bruce Melancon; Victor P Ghidu; Gary A Sulikowski; Bonnie LaFleur; Adrian Salic; Laura A Lee; David M Miller; Ethan Lee
Journal:  Nat Chem Biol       Date:  2010-10-03       Impact factor: 15.040

3.  Role of TAZ as mediator of Wnt signaling.

Authors:  Luca Azzolin; Francesca Zanconato; Silvia Bresolin; Mattia Forcato; Giuseppe Basso; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Cell       Date:  2012-12-13       Impact factor: 41.582

4.  N-terminal PDZ-like domain of chromatin organizer SATB1 contributes towards its function as transcription regulator.

Authors:  Dimple Notani; Praveena L Ramanujam; P Pavan Kumar; Kamalvishnu P Gottimukkala; Chandan Kumar-Sinha; Sanjeev Galande
Journal:  J Biosci       Date:  2011-08       Impact factor: 1.826

5.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

6.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

7.  Upregulation of SATB1 is associated with the development and progression of glioma.

Authors:  Sheng-Hua Chu; Yan-Bin Ma; Dong-Fu Feng; Hong Zhang; Zhi-An Zhu; Zhi-Qiang Li; Pu-Cha Jiang
Journal:  J Transl Med       Date:  2012-07-28       Impact factor: 5.531

8.  SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.

Authors:  Jie Zhang; Baogang Zhang; Xumei Zhang; Yingui Sun; Xiaolong Wei; Michael A McNutt; Shijun Lu; Yuqing Liu; Donghong Zhang; Mingyu Wang; Zhijuan Lin; Na Niu
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

9.  ATM suppresses SATB1-induced malignant progression in breast epithelial cells.

Authors:  Ellen Ordinario; Hye-Jung Han; Saori Furuta; Laura M Heiser; Lakshmi R Jakkula; Francis Rodier; Paul T Spellman; Judith Campisi; Joe W Gray; Mina J Bissell; Yoshinori Kohwi; Terumi Kohwi-Shigematsu
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Expression of SATB1 promotes the growth and metastasis of colorectal cancer.

Authors:  Yi Zhang; Xiuyun Tian; Hong Ji; Xiaoya Guan; Wei Xu; Bin Dong; Min Zhao; Meng Wei; Chunxiang Ye; Yuan Sun; Xiaosun Yuan; Chen Yang; Chunyi Hao
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more
  37 in total

Review 1.  SATB family chromatin organizers as master regulators of tumor progression.

Authors:  Rutika Naik; Sanjeev Galande
Journal:  Oncogene       Date:  2018-11-09       Impact factor: 9.867

2.  Special AT-rich Sequence-binding Protein 1 (SATB1) Functions as an Accessory Factor in Base Excision Repair.

Authors:  Simran Kaur; Yan Coulombe; Zubaidah M Ramdzan; Lam Leduy; Jean-Yves Masson; Alain Nepveu
Journal:  J Biol Chem       Date:  2016-09-02       Impact factor: 5.157

3.  Tetramerization of SATB1 is essential for regulating of gene expression.

Authors:  Minying Zheng; Wancai Xing; Yabing Liu; Meng Li; Hao Zhou
Journal:  Mol Cell Biochem       Date:  2017-02-15       Impact factor: 3.396

Review 4.  'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Authors:  Mei S Ong; Wanpei Cai; Yi Yuan; Hin C Leong; Tuan Z Tan; Asad Mohammad; Ming L You; Frank Arfuso; Boon C Goh; Sudha Warrier; Gautam Sethi; Nicholas S Tolwinski; Peter E Lobie; Celestial T Yap; Shing C Hooi; Ruby Y Huang; Alan P Kumar
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

5.  USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization.

Authors:  Chenming Wu; Kuntian Luo; Fei Zhao; Ping Yin; Ying Song; Min Deng; Jinzhou Huang; Yuping Chen; Lei Li; SeungBaek Lee; JungJin Kim; Qin Zhou; Xinyi Tu; Somaira Nowsheen; Qifeng Luo; Xiumei Gao; Zhenkun Lou; Zhongmin Liu; Jian Yuan
Journal:  Cell Death Differ       Date:  2018-06-04       Impact factor: 15.828

6.  Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response.

Authors:  Rafeeq Mir; Ankita Sharma; Saurabh J Pradhan; Sanjeev Galande
Journal:  Mol Cell Biol       Date:  2018-10-29       Impact factor: 4.272

7.  Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro.

Authors:  Wenbai Huang; Zhan'ao Liu; Guanzhou Zhou; Jianmin Ling; Ailing Tian; Nianfeng Sun
Journal:  Tumour Biol       Date:  2016-02-04

8.  LRP16 prevents hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.

Authors:  Lijuan Shao; Wei Jing; Lingxiong Wang; Fei Pan; Liangliang Wu; Lijun Zhang; Pan Yang; Minggen Hu; Kexing Fan
Journal:  J Mol Med (Berl)       Date:  2018-05-11       Impact factor: 4.599

9.  PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Authors:  Fu-Chun Huo; Yao-Jie Pan; Tong-Tong Li; Jie Mou; Dong-Sheng Pei
Journal:  Cell Death Differ       Date:  2018-08-06       Impact factor: 15.828

10.  ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer.

Authors:  Yue-Ju Li; Cheng-Ning Yang; Mark Yen-Ping Kuo; Wei-Ting Lai; Tai-Sheng Wu; Been-Ren Lin
Journal:  Ann Surg Oncol       Date:  2021-06-19       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.